Articles on Cardiovascular Disease

Recently published by URMC faculty

 

April 2009

“Invasion of human coronary artery endothelial cells by Streptococcus mutans OMZ175.” Abranches J, Zeng L, Bélanger M, Rodrigues PH, Simpson-Haidaris PJ, Akin D, Dunn WA Jr, Progulske-Fox A, Burne RA. Oral Microbiol Immunol. 2009 Apr;24(2):141-5.

March 2009

“Hypercholesterolemia among children: when is it high, and when is it really high?” Cook S. Circulation. 2009 Mar 3;119(8):1075-7.

“New insights into cancer-associated thrombosis.” Sousou T, Khorana AA. Arterioscler Thromb Vasc Biol. 2009 Mar;29(3):316-20.

February 2009

“The complex II inhibitor atpenin A5 protects against cardiac ischemia-reperfusion injury via activation of mitochondrial K(ATP) channels.” Wojtovich AP, Brookes PS. Basic Res Cardiol. 2009 Feb 26. [Epub ahead of print]

“PKC activation and PIP(2) depletion underlie biphasic regulation of IKs by Gq-coupled receptors.” Matavel A, Lopes CM. J Mol Cell Cardiol. 2009 Feb 19. [Epub ahead of print]

“Pheochromocytoma: presenting with regular cyclic blood pressure and inverted takotsubo cardiomyopathy.” Jindal V, Baker ML, Aryangat A, Wittlin SD, Bisognano JD, Richter HS. J Clin Hypertens (Greenwich). 2009 Feb;11(2):81-6.

“Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy.” Pearson TA, Ballantyne CM, Veltri E, Shah A, Bird S, Lin J, Rosenberg E, Tershakovec AM. Am J Cardiol. 2009 Feb 1;103(3):369-74. Epub 2008 Oct 30.

“Effect of gender on cardiovascular risk stratification with ECG gated SPECT left ventricular volume indices and ejection fraction.” Wexler O, Yoder SR, Elder JL, Mackin ML, Chen L, Mixon L, Schwartz RG. J Nucl Cardiol. 2009 Feb;16(1):28-37. Epub 2009 Jan 20.

“Baroreflex device therapy in the treatment of hypertension.” Uppuluri SC, Storozynsky E, Bisognano JD. Curr Hypertens Rep. 2009 Feb;11(1):69-75.

January 2009

“Relation of brain natriuretic peptide level to extent of left ventricular scarring in patients with chronic heart failure secondary to ischemic cardiomyopathy.” Aktas MK, Allen D, Jaber WA, Chuang HH, Taylor DO, Yamani MH. Am J Cardiol. 2009 Jan 15;103(2):243-5. Epub 2008 Nov 7.

“Increased Cardiovascular Risk Associated with Reduced Kidney Function.” Ryan TP, Fisher SG, Elder JL, Winters PC, Beckett W, Tacci J, Sloand JA. Am J Nephrol. 2009 Jan 19;29(6):620-625. [Epub ahead of print]

“Access strategies for peripheral arterial intervention.” Narins CR. Cardiol J. 2009;16(1):88-97.

“Implantable electrocardiographic monitoring devices.” Rosero SZ. Cardiol J. 2009;16(1):86-7.

December 2008

“Screening adolescents for lipid disorders: what is the best approach?” Jenssen BP, Jacobson MS. Adolesc Med State Art Rev. 2008 Dec;19(3):507-20, x.

“Disruption of Striated Preferentially Expressed Gene Locus Leads to Dilated Cardiomyopathy in Mice.” Liu X, Ramjiganesh T, Chen YH, Chung SW, Hall SR, Schissel SL, Padera RF Jr, Liao R, Ackerman KG, Kajstura J, Leri A, Anversa P, Yet SF, Layne MD, Perrella MA. Circulation. 2008 Dec 31; [Epub ahead of print]

“Omega-6 and trans fatty acids in blood cell membranes: a risk factor for acute coronary syndromes?” Block RC, Harris WS, Reid KJ, Spertus JA. Am Heart J. 2008 Dec;156(6):1117-23. Epub 2008 Oct 14

“Risks and Challenges of Implantable Cardioverter-Defibrillators in Young Adults.” Sherrid MV, Daubert JP. Prog Cardiovasc Dis. 2008 November - December;51(3):237-263.

November 2008

“GIT1 Mediates VEGF-Induced Podosome Formation in Endothelial Cells. Critical Role for PLC{gamma}” Wang J, Taba Y, Pang J, Yin G, Yan C, Berk BC. Arterioscler Thromb Vasc Biol. 2008 Nov 20; [Epub ahead of print]

“Bcr Kinase Activation by Angiotensin II Inhibits Peroxisome Proliferator-Activated Receptor {gamma} Transcriptional Activity in Vascular Smooth Muscle Cells.” Alexis JD, Wang N, Che W, Lerner-Marmarosh N, Sahni A, Korshunov VA, Zou Y, Ding B, Yan C, Berk BC, Abe JI. Circ Res. 2008 Nov 20; [Epub ahead of print]

“Serotonin and Angiotensin Receptors in Cardiac Fibroblasts Coregulate Adrenergic-Dependent Cardiac Hypertrophy.” Jaffre F, Bonnin P, Callebert J, Debbabi H, Setola V, Doly S, Monassier L, Mettauer B, Blaxall BC, Launay JM, Maroteaux L. Circ Res. 2008 Nov 20; [Epub ahead of print]

“Long QT Syndrome and Short QT Syndrome.” Zareba W, Cygankiewicz I. Prog Cardiovasc Dis. 2008 Nov-Dec;51(3):264-78.

“Recurrent ventricular arrhythmia storms in the age of implantable cardioverter defibrillator therapy: a comprehensive review.” Huang DT, Traub D. Prog Cardiovasc Dis. 2008 Nov-Dec;51(3):229-36.

“A Prospective, randomized trial of topical hemostasis patch use following percutaneous coronary and peripheral intervention.” Narins CR, Zareba W, Rocco V, McNitt S. J Invasive Cardiol. 2008 Nov;20(11):579-84.

“ECG Parameters and Exposure to Carbon Ultrafine Particles in Young Healthy Subjects.” Zareba W, Couderc JP, Oberdorster G, Chalupa D, Cox C, Huang LS, Peters A, Utell MJ, Frampton MW. Inhal Toxicol. 2008 Nov 7:1. [Epub ahead of print]

October 2008

“Efficacy of Medical Therapy for the Reduction of Heart Failure Events in Patients with Implanted Cardioverter Defibrillators.” Pietrasik G, Goldenberg I, McNitt S, Polonsky B, Moss AJ, Zareba W. J Cardiovasc Electrophysiol. 2008 Oct 22; [Epub ahead of print]

“Acetaldehyde stimulates monocyte adhesion in a P-selectin- and TNFalpha-dependent manner.” Redmond EM, Morrow D, Kundimi S, Miller-Graziano CL, Cullen JP. Atherosclerosis. 2008 Oct 18; [Epub ahead of print]

“Baseline Values and Sotalol-Induced Changes of Ventricular Repolarization Duration, Heterogeneity, and Instability in Patients With a History of Drug-Induced Torsades de Pointes.” Couderc JP, Kaab S, Hinterseer M, McNitt S, Xia X, Fossa A, Beckmann BM, Polonsky S, Zareba W. J Clin Pharmacol. 2008 Oct 28. [Epub ahead of print]

“EPAC and phospholipase Cepsilon regulate Ca2+ release in the heart by activation of protein kinase Cepsilon and calcium-calmodulin-kinaseII.” Oestreich EA, Malik S, Goonasekera SA, Blaxall BC, Kelley GG, Dirksen RT, Smrcka AV. J Biol Chem. 2008 Oct 27. [Epub ahead of print]

“Long QT syndrome in patients over 40 years of age: increased risk for LQTS-related cardiac events in patients with coronary disease.” Sze E, Moss AJ, Goldenberg I, McNitt S, Jons C, Zareba W, Qi M, Robinson JL; International Long QT Syndrome Investigative Group. Ann Noninvasive Electrocardiol. 2008 Oct;13(4):327-31.

“Vascular smooth muscle-derived tissue factor is critical for arterial thrombosis after ferric chloride-induced injury.” Wang L, Miller C, Swarthout RF, Rao M, Mackman N, Taubman MB. Blood. 2008 Oct 17; [Epub ahead of print]

“Lp(a) and Risk of Recurrent Cardiac Events in Obese Postinfarction Patients.” Corsetti JP, Ryan D, Rainwater DL, Moss AJ, Zareba W, Block RC, Sparks CE. Obesity (Silver Spring). 2008 Oct 16; [Epub ahead of print]

“Risk of Cardiac Events in Patients With Asthma and Long-QT Syndrome Treated With Beta(2) Agonists.” Thottathil P, Acharya J, Moss AJ, Jons C, McNitt S, Goldenberg I, Zareba W, Kaufman E, Qi M, Robinson JL; International Long QT Syndrome InvestigativeGroup. Am J Cardiol. 2008 Oct 1;102(7):871-4. Epub 2008 Jul 17.

September 2008

“Prevalence of Metabolic Syndrome and Related Characteristics in Obese Adolescents with and without Polycystic Ovary Syndrome.” Rossi B, Sukalich S, Droz J, Griffin A, Cook S, Blumkin A, Guzick DS, Hoeger KM. J Clin Endocrinol Metab. 2008 Sep 23; [Epub ahead of print]

“Investigating the effect of sotalol on the repolarization intervals in healthy young individuals.” Couderc JP, Zhou M, Sarapa N, Zareba W. J Electrocardiol. 2008 Sep 16; [Epub ahead of print]

“A brief office educational intervention improved referral rates for hypertension control in women.” Lewis V, Barnhart J, Houghton JL, Charney P. Int J Cardiol. 2008 Sep 15; [Epub ahead of print]

“Implantable Cardioverter Defibrillator Efficacy and Chronic Kidney Disease: Competing Risks of Arrhythmic and Nonarrhythmic Mortality.” Goldenberg I, Moss AJ. J Cardiovasc Electrophysiol. 2008 Sep 3. [Epub ahead of print]

“ERKs/p53 Signal Transduction Pathway Is Involved in Doxorubicin-Induced Apoptosis in H9c2 Cells and Cardiomyocytes.” Liu J, Mao W, Ding B, Liang CS. Am J Physiol Heart Circ Physiol. 2008 Sep 5. [Epub ahead of print]

“Pro-apoptotic effects of anti-beta(1)-adrenergic receptor antibodies in cultured rat cardiomyocytes: Actions on endoplasmic reticulum and the prosurvival PI3K-Akt pathway.” Liang CS, Mao W, Liu J. Autoimmunity. 2008 Sep;41(6):434-41.

August 2008

“Women and heart disease: An update.” Quinn, Jill R. Nursing Management. 39(8):22-7, 2008 Aug.

“Reactive oxygen species-induced activation of p90 ribosomal S6 kinase prolongs cardiac repolarization through inhibiting outward K+ channel activity.” Lu, Zhibo. Abe, Jun-ichi. Taunton, Jack. Lu, Yan. Shishido, Tetsuro. McClain, Carolyn. Yan, Chen. Xu, Sheng Ping. Spangenberg, Thomas M. Xu, Haodong. Circulation Research. 103(3):269-78, 2008 Aug 1.

July 2008

“Predictive value of admission electrocardiography in patients with heart failure.” Zareba KM, Shenkman HJ, Bisognano JD. Congest Heart Fail. 2008 Jul-Aug;14(4):173-9.

“Long-term outcomes of endoluminal therapy for chronic atherosclerotic occlusive mesenteric disease.” Lee, Richard W.  Bakken, Andrew M.  Palchik, Eugene.  Saad, Wael E. Davies, Mark G.Annals of Vascular Surgery.  22(4):541-6, 2008 Jul-Aug.

“Ethanol stimulates endothelial cell angiogenic activity via a Notch- and angiopoietin-1-dependent pathway.” Morrow, David.  Cullen, John P.  Cahill, Paul A.  Redmond, Eileen M. Cardiovascular Research.  79(2):313-21, 2008 Jul 15.

“Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen species.” Yu, Tianzheng.  Sheu, Shey-Shing.  Robotham, James L.  Yoon, Yisang. Cardiovascular Research.  79(2):341-51, 2008 Jul 15.

“Frequency of Elevations in Markers of Cardiomyocyte Damage in Otherwise Healthy Newborns.” Lipshultz SE, Simbre VC 2nd, Hart S, Rifai N, Lipsitz SR, Reubens L, Sinkin RA. Am J Cardiol. 2008 Sep 15;102(6):761-766. Epub 2008 Jul 9.